Phase 3
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Squamous Cell
Both
Carcinoma, Squamous Cell
Trial Information
Inclusion Criteria
- 18 years or older
- Must have had radiation treatment
- Eligible for chemotherapy
- Not eligible for surgery
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Principal Investigator
Kerstin Menander, MD
Investigator Role:
Study Director
Authority:
United States: Food and Drug Administration
Study ID:
T302
NCT ID:
NCT00041626
Start Date:
Completion Date:
Related Keywords:
- Carcinoma, Squamous Cell
- Recurrent Squamous Cell Carcinoma of the Head and Neck
- Carcinoma
- Carcinoma, Squamous Cell
Name | Location |
|---|---|
| Norton Healthcare Pavilion | Louisville, Kentucky 40202 |
| Mary Crowley Medical Research Center | Dallas, Texas 75246 |
| University of Arkansas | Little Rock, Arkansas 72202 |
| Unversity of Colorado Cancer Center | Aurora, Colorado 80045 |
| WJB Dorn VA Medical Center | Columbia, South Carolina 29209 |
| University of Miami Hospital and Sylvester Comprehensive Cancer Center | Miami, Florida 33136 |
| Center Center of GBMC | Baltimore, Maryland 21204 |
| University of Texas, MD Andersen Cancer Center | Houston, Texas 77030 |
